HONOLULU--(BUSINESS WIRE)--Hawaii Biotech, Inc., today announced successful Phase 1 clinical trial results of its West Nile Virus vaccine in healthy volunteers. Hawaii Biotech is developing a West Nile recombinant sub-unit vaccine to induce protective immunity in recipients of the vaccine.
